Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes.

Autor: Liutkauskiene, Sigita1 sigita.liutkauskiene@lsmuni.lt, Grizas, Saulius2 saulius.grizas@lsmuni.lt, Jureniene, Kristina3 kristina.jureniene@lsmuni.lt, Suipyte, Jorune4 jorune.suipyte@gmail.com, Statnickaite, Akvile4 akvile.statnickaite@gmail.com, Juozaityte, Elona1 elona.juozaityte@lsmuni.lt
Zdroj: BMC Cancer. 4/20/2018, Vol. 18 Issue 1, p1-9. 9p. 1 Diagram, 1 Chart, 4 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje